Less Ads, More Data, More Tools Register for FREE

AstraZeneca pledges 9m more Covid vaccine jabs to EU

Mon, 01st Feb 2021 07:34

(Sharecast News) - AstraZeneca is set to supply an extra nine million doses of its Covid-19 vaccine to the European Union after a high-profile row over shortages.
European Commission President Ursula Von der Leyen said the extra doses will come in the first three months of the year, making a total of 40m for that period.

Von der Leyen said the company, which has production sites in the UK and on the Continent, will start deliveries one week earlier than planned and expand its manufacturing capacity in Europe.

The Anglo-Swiss pharmaceutical giant recently told Brussels the initial number of doses it could supply to the bloc would be lower than first thought, due to manufacturing issues, which sparked a dispute over supplies.

The pace of the vaccine rollout in the 27-member bloc has so far been slow and Von der Leyen admitted the situation would be "difficult" in March and April - but wanted 70% of adults in Europe to have a jab by the end of the summer.

Last week, AstraZeneca said it could bring forward some deliveries to the EU and offered eight million more jabs to the bloc in an attempt to defuse the row.

But an EU official said that was far short of what was originally promised as AstraZeneca had committed to at least 80 million shots in the first quarter of the year.

Related Shares

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...

28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...

27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.